High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance

Recently, cereblon (CRBN) expression was found to be essential for the activity of thalidomide and lenalidomide. In the present study, we investigated whether the clinical efficacy of thalidomide in multiple myeloma is associated with CRBN expression in myeloma cells. Patients with newly diagnosed m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Broyl, Annemiek (VerfasserIn) , Kuiper, Rowan (VerfasserIn) , van Duin, Mark (VerfasserIn) , van der Holt, Bronno (VerfasserIn) , el Jarari, Laila (VerfasserIn) , Bertsch, Uta (VerfasserIn) , Zweegman, Sonja (VerfasserIn) , Buijs, Arjan (VerfasserIn) , Hose, Dirk (VerfasserIn) , Lokhorst, Henk M. (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Sonneveld, Pieter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2013
In: Blood
Year: 2012, Jahrgang: 121, Heft: 4, Pages: 624-627
ISSN:1528-0020
DOI:10.1182/blood-2012-06-438101
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood-2012-06-438101
Volltext
Verfasserangaben:Annemiek Broyl, Rowan Kuiper, Mark van Duin, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Sonja Zweegman, Arjan Buijs, Dirk Hose, Henk M. Lokhorst, Hartmut Goldschmidt, and Pieter Sonneveld, for the Dutch-Belgian HOVON group and the German GMMG Group

MARC

LEADER 00000caa a2200000 c 4500
001 1742282911
003 DE-627
005 20230428160825.0
007 cr uuu---uuuuu
008 201208r20132012xx |||||o 00| ||eng c
024 7 |a 10.1182/blood-2012-06-438101  |2 doi 
035 |a (DE-627)1742282911 
035 |a (DE-599)KXP1742282911 
035 |a (OCoLC)1341383383 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Broyl, Annemiek  |e VerfasserIn  |0 (DE-588)1222999919  |0 (DE-627)1742283594  |4 aut 
245 1 0 |a High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance  |c Annemiek Broyl, Rowan Kuiper, Mark van Duin, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Sonja Zweegman, Arjan Buijs, Dirk Hose, Henk M. Lokhorst, Hartmut Goldschmidt, and Pieter Sonneveld, for the Dutch-Belgian HOVON group and the German GMMG Group 
264 1 |c 2013 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a prepublished online as BloodFirst Edition paper, December 11, 2012 
500 |a Gesehen am 08.12.2020 
520 |a Recently, cereblon (CRBN) expression was found to be essential for the activity of thalidomide and lenalidomide. In the present study, we investigated whether the clinical efficacy of thalidomide in multiple myeloma is associated with CRBN expression in myeloma cells. Patients with newly diagnosed multiple myeloma were included in the HOVON-65/GMMG-HD4 trial, in which postintensification treatment in 1 arm consisted of daily thalidomide (50 mg) for 2 years. Gene-expression profiling, determined at the start of the trial, was available for 96 patients who started thalidomide maintenance. In this patient set, increase of CRBN gene expression was significantly associated with longerprogression-free survival (P = .005). In contrast, no association between CRBN expression and survival was observed in the arm with bortezomib maintenance. We conclude that CRBN expression may be associated with the clinical efficacy of thalidomide. This trial has been registered at the Nederlands Trial Register (www.trialregister.nl) as NTR213; at the European Union Drug Regulating Authorities Clinical Trials (EudraCT) as 2004-000944-26; and at the International Standard Randomized Controlled Trial Number (ISRCTN) as 64455289. 
534 |c 2012 
700 1 |a Kuiper, Rowan  |e VerfasserIn  |4 aut 
700 1 |a van Duin, Mark  |e VerfasserIn  |4 aut 
700 1 |a van der Holt, Bronno  |e VerfasserIn  |4 aut 
700 1 |a el Jarari, Laila  |e VerfasserIn  |4 aut 
700 1 |a Bertsch, Uta  |e VerfasserIn  |0 (DE-588)1026849861  |0 (DE-627)727494163  |0 (DE-576)372176224  |4 aut 
700 1 |a Zweegman, Sonja  |e VerfasserIn  |4 aut 
700 1 |a Buijs, Arjan  |e VerfasserIn  |4 aut 
700 1 |a Hose, Dirk  |d 1969-  |e VerfasserIn  |0 (DE-588)139824995  |0 (DE-627)613790308  |0 (DE-576)313431698  |4 aut 
700 1 |a Lokhorst, Henk M.  |e VerfasserIn  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Sonneveld, Pieter  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 121(2013), 4, Seite 624-627  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance 
773 1 8 |g volume:121  |g year:2013  |g number:4  |g pages:624-627  |g extent:4  |a High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance 
856 4 0 |u https://doi.org/10.1182/blood-2012-06-438101  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201208 
993 |a Article 
994 |a 2013 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |d 50000  |e 910000PG102258023X  |e 910100PG102258023X  |e 50000PG102258023X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 11 
998 |g 139824995  |a Hose, Dirk  |m 139824995:Hose, Dirk  |d 910000  |d 910100  |e 910000PH139824995  |e 910100PH139824995  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 1026849861  |a Bertsch, Uta  |m 1026849861:Bertsch, Uta  |d 910000  |d 910100  |d 50000  |e 910000PB1026849861  |e 910100PB1026849861  |e 50000PB1026849861  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 6 
999 |a KXP-PPN1742282911  |e 3819277080 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"note":["prepublished online as BloodFirst Edition paper, December 11, 2012","Gesehen am 08.12.2020"],"title":[{"title_sort":"High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance","title":"High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1742282911","relHost":[{"id":{"eki":["266886647"],"issn":["1528-0020"],"zdb":["1468538-3"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"266886647","disp":"High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenanceBlood","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1946 -"],"origin":[{"publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedDisp":"1946-","dateIssuedKey":"1946","publisher":"American Society of Hematology ; Saunders ; HighWire Press"}],"note":["Gesehen am 21.04.2023"],"title":[{"title_sort":"Blood","subtitle":"journal of the American Society of Hematology","title":"Blood"}],"titleAlt":[{"title":"Blood online"}],"part":{"extent":"4","volume":"121","issue":"4","text":"121(2013), 4, Seite 624-627","pages":"624-627","year":"2013"},"language":["eng"],"corporate":[{"role":"isb","display":"American Society of Hematology"}]}],"name":{"displayForm":["Annemiek Broyl, Rowan Kuiper, Mark van Duin, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Sonja Zweegman, Arjan Buijs, Dirk Hose, Henk M. Lokhorst, Hartmut Goldschmidt, and Pieter Sonneveld, for the Dutch-Belgian HOVON group and the German GMMG Group"]},"physDesc":[{"extent":"4 S."}],"id":{"doi":["10.1182/blood-2012-06-438101"],"eki":["1742282911"]},"person":[{"display":"Broyl, Annemiek","family":"Broyl","given":"Annemiek","role":"aut"},{"family":"Kuiper","display":"Kuiper, Rowan","role":"aut","given":"Rowan"},{"display":"van Duin, Mark","family":"van Duin","role":"aut","given":"Mark"},{"role":"aut","given":"Bronno","family":"van der Holt","display":"van der Holt, Bronno"},{"given":"Laila","role":"aut","display":"el Jarari, Laila","family":"el Jarari"},{"given":"Uta","role":"aut","display":"Bertsch, Uta","family":"Bertsch"},{"display":"Zweegman, Sonja","family":"Zweegman","role":"aut","given":"Sonja"},{"given":"Arjan","role":"aut","family":"Buijs","display":"Buijs, Arjan"},{"given":"Dirk","role":"aut","display":"Hose, Dirk","family":"Hose"},{"role":"aut","given":"Henk M.","display":"Lokhorst, Henk M.","family":"Lokhorst"},{"role":"aut","given":"Hartmut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"display":"Sonneveld, Pieter","family":"Sonneveld","given":"Pieter","role":"aut"}],"language":["eng"]} 
SRT |a BROYLANNEMHIGHCEREBL2013